Abstract
Introduction: Intranasal drug administration is a non-invasive method of bypassing the blood—brain barrier (BBB) to deliver therapeutic agents to the brain and spinal cord. This method also delivers those drugs that do not cross the BBB to the central nervous system (CNS) thus eliminating the need for systemic delivery, and subsequently reducing the unwanted systemic side effects. Delivery from the nose- to-brain occurs within minutes along both the olfactory and trigeminal neural pathways. Materials and Methods: Rat model was developed to determine existence of neural and non neural pathways after nasal delivery in rats. For the study mucoadhesive nanoparticles were prepared by ionic crosslinking method and the study was investigated using intranasal administration of Tc99m labeled chitosan nanoparticulate formulation in dead and alive rats. Result: The result showed a significant increase of 4.4 times radiolabeled drug concentration in the brain of live rats as compared to the radiolabeled drug concentration in the dead rats (p < 0.01). Conclusion This experimental rat model provides a proof for existence of neural and non-neural pathway for nose to brain using a novel formulation for crossing BBB which is of importance in finding a solution for neurodegenerative disorders.
Keywords: Olfactory, trigeminal, radiolabeled, nose-to-brain, nasal drug delivery, neural, non-neural
Current Nanoscience
Title: Reflection on Existence of Neural and Non-Neural Pathway for Nose- to- Brain Using a Novel Formulation of an Anticholinesterase Piperidine Derivative
Volume: 6 Issue: 3
Author(s): Javed Ali, Mushir Ali, Sanjula Baboota, Rashid Ali, Gaurav Mittal, Aseem Bhatnagar and Bhavna
Affiliation:
Keywords: Olfactory, trigeminal, radiolabeled, nose-to-brain, nasal drug delivery, neural, non-neural
Abstract: Introduction: Intranasal drug administration is a non-invasive method of bypassing the blood—brain barrier (BBB) to deliver therapeutic agents to the brain and spinal cord. This method also delivers those drugs that do not cross the BBB to the central nervous system (CNS) thus eliminating the need for systemic delivery, and subsequently reducing the unwanted systemic side effects. Delivery from the nose- to-brain occurs within minutes along both the olfactory and trigeminal neural pathways. Materials and Methods: Rat model was developed to determine existence of neural and non neural pathways after nasal delivery in rats. For the study mucoadhesive nanoparticles were prepared by ionic crosslinking method and the study was investigated using intranasal administration of Tc99m labeled chitosan nanoparticulate formulation in dead and alive rats. Result: The result showed a significant increase of 4.4 times radiolabeled drug concentration in the brain of live rats as compared to the radiolabeled drug concentration in the dead rats (p < 0.01). Conclusion This experimental rat model provides a proof for existence of neural and non-neural pathway for nose to brain using a novel formulation for crossing BBB which is of importance in finding a solution for neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Ali Javed, Ali Mushir, Baboota Sanjula, Ali Rashid, Mittal Gaurav, Bhatnagar Aseem and Bhavna , Reflection on Existence of Neural and Non-Neural Pathway for Nose- to- Brain Using a Novel Formulation of an Anticholinesterase Piperidine Derivative, Current Nanoscience 2010; 6 (3) . https://dx.doi.org/10.2174/157341310791171135
DOI https://dx.doi.org/10.2174/157341310791171135 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteasomes as Drug Targets
Current Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry Polyglutamine and Neurodegeneration: Structural Aspects
Protein & Peptide Letters Melatonin Therapy of Pediatric Sleep Disorders: Recent Advances, Why it Works, Who are the Candidates and How to Treat
Current Pediatric Reviews Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Protein & Peptide Letters Mapping Chemical Space Using Molecular Descriptors and Chemical Genetics: Deacetylase Inhibitors
Combinatorial Chemistry & High Throughput Screening Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders
Current Medicinal Chemistry Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications
Current Pharmaceutical Biotechnology Microglial Activation and its Implications in the Brain Diseases
Current Medicinal Chemistry The Mitochondrial Unfolded Protein Response: Role in Cellular Homeostasis and Disease
Current Molecular Medicine FTIR Spectroscopy Analysis can Highlight Induced Damage in Neuronallike Cells and Bio-protective Effectiveness of Agmatine
Current Metabolomics Traditional Fruits of Kerala: Bioactive Compounds and their Curative Potential in Chronic Diseases
Current Nutrition & Food Science The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A Review and Synthesis of Biological Mechanisms
Current Molecular Medicine Sub-Chronic Exposure of Non-Observable Adverse Effect Dose of Terbufos Sulfone: Neuroinflammation in Diabetic and Non-Diabetic Rats
CNS & Neurological Disorders - Drug Targets Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways
Current Signal Transduction Therapy PET Radiotracers for Molecular Imaging in Dementia
Current Radiopharmaceuticals Progress in Imaging Agents of Cell Apoptosis
Anti-Cancer Agents in Medicinal Chemistry C-Peptide and its Correlation to Parameters of Insulin Resistance in the Metabolic Syndrome
CNS & Neurological Disorders - Drug Targets Pharmacotherpy and Alzheimer’s Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach
Current Pharmaceutical Design